USP21 promotes KRAS∗-independent cancer development via the mTOR signaling pathway by MARK3-mediated up-regulation of macropinocytosis, which helps to fulfil the anabolic requirements (Hou et al., 2021). The gene discussed is MTOR; the disease is cancer.